Impaired endothelial function in coronary heart disease patients with depressive symptomatology

被引:217
|
作者
Sherwood, A
Hinderliter, AL
Watkins, LL
Waugh, RA
Blumenthal, JA
机构
[1] Duke Univ, Med Ctr, Durham, NC 27710 USA
[2] Univ N Carolina, Chapel Hill, NC USA
关键词
D O I
10.1016/j.jacc.2005.05.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The purpose of this study was to assess whether depressive symptomatology was, associated with vascular endothelial dysfunction in patients with coronary heart disease (CHD). BACKGROUND In patients with CHD, the presence of depression is associated with a two to four times increased risk of mortality, but the disease pathways involved are uncertain. Endothelial dysfunction is an established risk factor for cardiovascular events in patient with CHD. METHODS Flow-mediated dilation (FMD) of the brachial artery, it measure of endothelial function, was assessed in 143 patients (99 men, 44 -women), ages 40 to 84 years (mean age, 63 +/- 10 years), with documented CHD. RESULTS Patients with significant depressive symptomatology, as indicated by a Beck Depression Inventory (BDI) score >= 10 (n = 47) showed attenuated FMD (p = 0.001) compared with patients that were not depressed (BDI < 10; n = 96). The use of antidepressant medication was associated with improved FMD (p < 0.05). CONCLUSIONS The increased risk of cardiovascular events in CHD patients with elevated symptoms of depression may be mediated, in part, by endothelial dysfunction. (c) 2005 by the American College of Cardiology Foundation.
引用
收藏
页码:656 / 659
页数:4
相关论文
共 50 条
  • [1] THE PREVALENCE OF METABOLIC SYNDROME IN CORONARY HEART DISEASE PATIENTS AND ITS RELATIONSHIP WITH DEPRESSIVE SYMPTOMATOLOGY
    Chariatis, V.
    Rallidis, L.
    Varounis, C.
    Vavoulis, P.
    Liakos, G.
    Fountoulaki, K.
    Komporozos, C.
    Matsakas, V.
    Lekakis, I.
    Kremastinos, D.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 132 - 132
  • [2] CONDITION OF ADHESIVE ENDOTHELIAL FUNCTION IN CORONARY HEART DISEASE PATIENTS
    Romanova, Valentyna
    ATHEROSCLEROSIS, 2017, 263 : E141 - E141
  • [3] Folate improves endothelial function in patients with coronary heart disease
    Doshi, S
    McDowell, I
    Moat, S
    Lewis, M
    Goodfellow, J
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (11) : 1505 - 1512
  • [4] Effect of Trimetazidine on Vascular Endothelial Function in Patients with Coronary Heart Disease
    Chen, Jinliang
    Miao, Yongguo
    Han, Ling
    Hou, Wenhua
    Ye, Xike
    Liu, Jianjuan
    Chen, Hongtao
    CIRCULATION, 2010, 122 (02) : E149 - E149
  • [5] No influence of ivabradine on endothelial function in patients with stable coronary heart disease
    Jochmann, N.
    Schroter, F.
    Gericke, C.
    Stangl, K.
    Baumann, G.
    Stangl, V.
    EUROPEAN HEART JOURNAL, 2012, 33 : 589 - 589
  • [6] Depressive symptomatology accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with chronic systolic heart failure
    Chrysohoou, C.
    Kotroyiannis, J.
    Metallinos, G.
    Pitsavos, C.
    Tousoulis, D.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1007 - 1007
  • [7] Elevated plasma levels of placental growth factor are associated with an impaired endothelial vasodilator function in patients with coronary heart disease
    Trepels, T
    Heeschen, C
    Schmidt-Lucke, C
    Zeiher, AM
    Fichtlscherer, S
    CIRCULATION, 2005, 112 (17) : U160 - U160
  • [8] Inflammation, depressive symptomatology, and coronary artery disease
    Appels, A
    Bär, FW
    Bär, J
    Bruggeman, C
    de Baets, M
    PSYCHOSOMATIC MEDICINE, 2000, 62 (05): : 601 - 605
  • [9] Microvascular endothelial function is impaired in the cutaneous circulation in patients with coronary artery disease.
    Agarwal, Sharad C.
    Allen, John
    Murray, Alan
    Purcell, Ian F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 240A - 240A
  • [10] ENDOTHELIAL DYSFUNCTION AND OXYGEN TRANSPORTING FUNCTION OF BLOOD IN PATIENTS WITH CORONARY HEART DISEASE
    Yankovskaya, L. V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 68 - 68